1. National surveillance of bacterial and fungal coinfection and secondary infection in COVID-19 patients in England: lessons from the first wave;Gerver;Clin Microbiol Infect,2021
2. Clinical outcomes in patients co-infected with COVID-19 and Staphylococcus aureus: a scoping review;Adalbert;BMC Infect Dis,2021
3. Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years;Johnson;J Antimicrob Chemother,2012
4. UKHSA. Annual epidemiological commentary: Gram-negative, MRSA and MSSA bacteraemia and C. difficile infection data, up to and including financial year April 2020 to March 2021. Available at: https://webarchive.nationalarchives.gov.uk/ukgwa/20220505200519/https://www.gov.uk/government/statistics/mrsa-mssa-and-e-coli-bacteraemia-and-c-difficile-infection-annual-epidemiological-commentary. [Accessed September 2023].
5. UKHSA. Mandatory enhanced MRSA, MSSA and Gram-negative bacteraemia, and Clostridioides difficile infection surveillance. Protocol version 4.4 2020 [24/03/2023]. Available at: https://hcaidcs.phe.org.uk/ContentManagement/LinksAndAnnouncements/HCAIDCS_Mandatory_Surveillance_Protocol_v4.4.pdf.